Michael Wayne Lowry
Known title: SVP, Corporate ControllerCIK: 0001569290
Associated companies
Transaction History
| ACH | ▼ Sell | Tax Withholding | 1,533 | $11K | 5/15/2025 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,059 | $11K | 3/20/2025 | View on chart |
| ACH | ▲ Buy | Grant | 28,166 | $0 | 3/3/2025 | View on chart |
| ACH | ▲ Buy | Grant | 19,202 | $0 | 7/1/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 2,077 | $41K | 5/15/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 3,086 | $77K | 3/15/2024 | View on chart |
| ACH | ▲ Buy | Grant | 10,654 | $0 | 3/1/2024 | View on chart |
| ACH | ▼ Sell | Open Market | 10,000 | $250K | 2/27/2024 | View on chart |
| ACH | ▲ Buy | Grant | 555 | $9K | 12/29/2023 | View on chart |
| ACH | ▲ Buy | Grant | 739 | $12K | 6/30/2023 | View on chart |
| ACH | ▼ Sell | Open Market | 10,000 | $211K | 6/6/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 928 | $17K | 5/15/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,453 | $27K | 5/11/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 8,923 | $117K | 3/15/2023 | View on chart |
| ACH | ▲ Buy | Grant | 11,335 | $0 | 3/1/2023 | View on chart |
| ACH | ▲ Buy | Grant | 10,252 | $0 | 3/1/2023 | View on chart |
| ACH | ▲ Buy | Grant | 726 | $12K | 12/30/2022 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 786 | $28K | 5/16/2022 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 2,176 | $82K | 5/11/2022 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 21,058 | $901K | 3/4/2022 | View on chart |
| ACH | ▲ Buy | Grant | 4,092 | $0 | 3/3/2022 | View on chart |
| ACH | ▲ Buy | Grant | 29,242 | $0 | 2/9/2022 | View on chart |
| ACH | ▼ Sell | Open Market | 883 | $37K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 184 | $8K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 4,261 | $177K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 1,348 | $61K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 501 | $21K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 1,500 | $64K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 3,474 | $144K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 138 | $6K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 400 | $18K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 517 | $23K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 5,169 | $214K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 6,452 | $267K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 4,104 | $174K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 2,500 | $107K | 11/3/2021 | View on chart |
| ACH | ▼ Sell | Open Market | 1,200 | $53K | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice
Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.